RENETX BIO, INC.

Profile

Company Names

RENETX BIO, INC.
AXERION THERAPEUTICS, INC.

Addresses

157 CHURCH STREET, 19TH FLOOR, NEW HAVEN, CT 06510

555 LONG WHARF DRIVE, 11TH FLOOR, NEW HAVEN, CT 06511

Phone Numbers

(203) 444-6642
(203) 773-1195

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$7,176,519.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-11-27 
$2,800,000.00 
$2,800,000.00 
$0.00 
Equity 
3
2018-03-29 
$3,193,548.00 
$3,193,548.00 
$0.00 
Equity 
2
2017-07-18 
$425,000.00 
$450,000.00 
$25,000.00 
Equity 
1
2010-04-01 
$757,971.00 
$757,971.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AMANDA 
 
HAYWARD 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
AXERION THERAPEUTICS, INC.   |  ONCOSYNERGY, INC.
JANE 
 
HENDERSON 
EXECUTIVE OFFICER
AXERION THERAPEUTICS, INC.   |  VIRGINIA COMMUNITY CAPITAL, INC.   |  TURNSTONE BIOLOGICS CORP.   |  ADAGIO THERAPEUTICS, INC.
GREGORY 
 
HO 
DIRECTOR
ISOPLEXIS CORP   |  RENETX BIO, INC.   |  ATLASXOMICS INC.   |  SMC GROWTH CAPITAL PARTNERS III, LP   |  EPISTEME PROGNOSTICS, INC.
SCHEER INVESTMENT 
 
HOLDINGS X, LLC 
PROMOTER
AXERION THERAPEUTICS, INC.
GEORGE 
 
MAYNARD 
EXECUTIVE OFFICER
RENETX BIO, INC.
SYLVIA 
 
MCBRINN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
AXERION THERAPEUTICS, INC.
JOHN 
 
PUZISS 
DIRECTOR
RENETX BIO, INC.
DAVID 
I. 
SCHEER 
DIRECTOR, PROMOTER
OPTHERION INC   |  AXERION THERAPEUTICS, INC.   |  ACHILLION PHARMACEUTICALS INC
ERIKA 
 
SMITH 
EXECUTIVE OFFICER, DIRECTOR
RENETX BIO, INC.   |  NEXTSTEP ROBOTICS, INC.
ERIKA 
R. 
SMITH 
EXECUTIVE OFFICER, DIRECTOR
RENETX BIO, INC.
STEPHEN 
 
STRITTMATTER 
PROMOTER
AXERION THERAPEUTICS, INC.   |  ALLYX THERAPEUTICS, INC.
DAVID 
 
WURZER 
DIRECTOR
RETAIL OPTIMIZATION INC.   |  CYVEK, INC.   |  NOVATRACT SURGICAL, INC.   |  EMME E2MS, LLC   |  RENETX BIO, INC.   |  SUMMIT THERAPEUTICS PLC   |  SHORELINE BIOME, LLC   |  BACTANA CORP.   |  ENKO CHEM, INC.
DAVID 
M. 
WURZER 
DIRECTOR
AXERION THERAPEUTICS, INC.   |  THETIS PHARMACEUTICALS LLC   |  STANDARD DIVERSIFIED OPPORTUNITIES INC.   |  BIOASIS TECHNOLOGIES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-09-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-27 
2019-12-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-27 
2019-07-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-29 
2018-04-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-29 
2017-12-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-18 
2010-04-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-04-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#